<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37195113</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1660-9379</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>827</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Revue medicale suisse</Title><ISOAbbreviation>Rev Med Suisse</ISOAbbreviation></Journal><ArticleTitle>[Psychiatric dimensions of post-COVID-19 condition : an overview].</ArticleTitle><Pagination><StartPage>975</StartPage><EndPage>978</EndPage><MedlinePgn>975-978</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.53738/REVMED.2023.19.827.975</ELocationID><Abstract><AbstractText>In the aftermath of the SARS-CoV-2 pandemic, many patients developed a set of persistent and disabling symptoms, commonly referred to as "long COVID" and defined as "post-COVID-19 condition" by the World Health Organization. The multi-systemic impairments caused by this condition include neuropsychiatric symptoms characterized by the presence of fatigue, cognitive and sleep disturbances, and increased rates of mood and anxiety disorders. Despite their high incidence and a significant risk of chronicity, they remain poorly understood. This article provides an overview of the psychiatric aspects of post-COVID-19 condition and their treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berney</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de psychiatrie de liaison, D&#xe9;partement de psychiatrie, Centre hospitalier universitaire vaudois, 1011 Lausanne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marillier</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de psychiatrie de liaison, D&#xe9;partement de psychiatrie, Centre hospitalier universitaire vaudois, 1011 Lausanne.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Dimensions psychiatriques de l&#x2019;affection post-Covid-19 : &#xe9;tat des lieux.</VernacularTitle></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Rev Med Suisse</MedlineTA><NlmUniqueID>101219148</NlmUniqueID><ISSNLinking>1660-9379</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Au d&#xe9;cours de la pand&#xe9;mie de SARS-CoV-2 sont apparus chez de nombreux patients un ensemble de sympt&#xf4;mes persistants et invalidants, commun&#xe9;ment appel&#xe9; &#xab; Covid long &#xbb; et d&#xe9;fini comme &#xab; affection post-Covid-19 &#xbb; par l&#x2019;OMS. Les atteintes multisyst&#xe9;miques provoqu&#xe9;es par cette affection comprennent des sympt&#xf4;mes neuropsychiatriques caract&#xe9;ris&#xe9;s, notamment une fatigue, des troubles cognitifs et des taux &#xe9;lev&#xe9;s de troubles de l&#x2019;humeur et anxieux. Malgr&#xe9; leur incidence &#xe9;lev&#xe9;e et un risque important de chronicit&#xe9;, ils restent mal connus. Cet article propose une synth&#xe8;se et une mise &#xe0; jour des connaissances au sujet des dimensions psychiatriques de l&#x2019;affection post-Covid-19 et de leurs prises en charge.</AbstractText></OtherAbstract><CoiStatement>Les auteurs n&#x2019;ont d&#xe9;clar&#xe9; aucun conflit d&#x2019;int&#xe9;r&#xea;ts en relation avec cet article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37195113</ArticleId><ArticleId IdType="doi">10.53738/REVMED.2023.19.827.975</ArticleId><ArticleId IdType="pii">RMS0827-010</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>